Clinical Trials Directory

Trials / Completed

CompletedNCT02010918

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

A Phase III, Multicenter, Randomized, Parallel, Open Label and Comparative Study to Evaluate the Efficacy of 500 mg Glucosamine Sulfate (GS) / 400 mg Chondroitin Sulfate (CS)Capsules and 1500 mg GS / 1200 mg CS Sachet Compared With Cosamin DS® Capsule in Treatment of Knee Osteoarthritis..

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
922 (actual)
Sponsor
Ache Laboratorios Farmaceuticos S.A. · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether 500 mg Glucosamine Sulfate / 400 mg Chondroitin Sulfate Capsules and 1500 mg Glucosamine Sulfate / 1200 mg Chondroitin Sulfate Sachet is effective and safe compared Cosamin DS ® Capsule in Treatment of Knee Osteoarthritis.

Detailed description

The Groups receive treatment for 16 weeks. The study is realized in 16 sites in Brazil.

Conditions

Interventions

TypeNameDescription
DRUGglucosamine sulfate /chondroitin sulfate - capsules500 mg glucosamine sulfate + 400 mg chondroitin sulfate - capsules; One capsule, three times daily.
DRUGglucosamine sulfate /chondroitin sulfate - sachet1500 mg glucosamine sulfate / 1200 mg chondroitin sulfate - sachet; One sachet preparation, once daily.
DRUGCosamin DS®500 mg glucosamine hydrochloride + 400 mg chondroitin sulfate - Capsules; One capsule, three times daily.

Timeline

Start date
2009-02-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2013-12-13
Last updated
2013-12-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02010918. Inclusion in this directory is not an endorsement.